Expression of Oestrogen Receptor Beta in Breast Cancer
Author Information
Author(s): Saunders P T K, Miller W R
Primary Institution: MRC Human Reproductive Sciences Unit, The University of Edinburgh
Conclusion
The study highlights the variability in detecting ERβ protein in breast cancer tissues and the factors that may influence these discrepancies.
Supporting Evidence
- Variations in assay sensitivity and specificity may lead to discrepancies in ERβ detection.
- Expression of ERβ variant proteins has been reported in other cancers, indicating broader implications.
- Poor tissue preservation can affect the reliability of ERβ detection.
Takeaway
This study talks about how scientists are trying to figure out why some tests for a protein related to breast cancer can give different results.
Methodology
The authors used various antibodies to study the expression of ERβ in breast cancer tissues.
Potential Biases
Potential misinterpretation of results due to poorly defined antibody specificity.
Limitations
The study acknowledges that variations in tissue fixation and antibody specificity can affect the detection of ERβ.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website